Connecting with Europe’s Cannabis Industry
Studio Bliss founder Evan Bliss attended PTMC 2026 (Portugal Medical Cannabis) in Lisbon, Portugal, joining cannabis industry professionals, researchers, and business leaders from across Europe and beyond.
The event provided an opportunity to explore developments in the European medical cannabis market, connect with international industry professionals, and discuss the growing importance of quality standards and compliant facility design.
Exploring Opportunities in European Cannabis
As Europe’s medical cannabis industry continues to evolve, operators face increasingly complex requirements around facility design, manufacturing processes, and regulatory compliance.
For Evan, attending PTMC was an opportunity to gain a closer perspective on the European market and connect with professionals navigating these challenges firsthand.
A key consideration for cannabis businesses looking to operate in European medical markets is EU-GMP (European Union Good Manufacturing Practice), which establishes quality standards for pharmaceutical manufacturing.
Understanding these requirements early in the facility planning process can help operators avoid costly design changes and better prepare for future certification.
Learn more in our guide: EU-GMP for Cannabis: Requirements Explained.
Supporting Cannabis Facility Development Worldwide
Studio Bliss specializes in cannabis facility design and architecture, helping operators plan efficient, functional, and compliance-focused facilities for cultivation, processing, manufacturing, and other cannabis operations.
Evan’s attendance at PTMC 2026 reflects Studio Bliss’s continued commitment to staying connected with international cannabis markets and understanding the evolving standards shaping facility development.
Planning a cannabis facility with GMP or EU-GMP requirements? Contact Studio Bliss to discuss your project and learn how our team can help.


